pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·1h ago·1 min read
save

WHO issues first global guidelines on childhood and adolescent obesity

Oct 7, 2026·read at STAT ↗RegulatoryNeutral

The World Health Organization has released its inaugural set of guidelines aimed at tackling the rapid increase in obesity among children and adolescents. The agency notes that in 2024, about 170 million individuals aged 5‑19 were living with obesity, including roughly 70 million children.

The new recommendations focus on prevention, early detection, and comprehensive management strategies, urging coordinated action across health systems, schools, families, and communities to curb the trend.

The announcement arrives alongside other industry developments, such as the Department of Justice’s heightened scrutiny of pharmaceutical practices and the shutdown of Caribou Biosciences after it could not secure funding for a CAR‑T clinical trial, underscoring broader challenges facing the sector.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Pharmalittle: We’re reading about WHO obesity guidelines for kids, DOJ targeting pharma, and more”

read at STAT ↗
680 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
ASTRAZENECARISING
drugs
Obesity9
topics
Obesity10CAR-T3CRISPR/Cas92DLBCL

related stories

  • 6h agoSTAT+: Caribou Biosciences, biotech co-founded by Jennifer Doudna, is shutting downSTAT
  • 10h ago5 biggest venture capital raises of Q3 2026BioSpace
  • Sep 29STAT+: AstraZeneca invests $2 billion in Summit TherapeuticsSTAT
  • Sep 28Trump uses ‘contested’ power to cut more funding to HHSSTAT
  • Sep 14Cellectis cans allogeneic CAR-Ts to hop aboard in vivo bandwagonFierce Biotech